Degludec

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk

Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion

The New Year began with the JP Morgan Healthcare Conference— the drug industry’s annual

India steps up efforts to improve drug quality; Allergan vows to limit price hikes

This week, Phispers has two news items that demonstrate Indian government’s keenness to improv